Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Zanubrutinib
Related studies linked through entity extraction aliases.
Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
- Status
- RECRUITING
- Phase
- N/A
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Relative Bioavailability of Zanubrutinib Tablets Compared to Capsules and Effects of Food on the Pharmacokinetics of the Tablet in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients
- Status
- TERMINATED
- Phase
- PHASE2
Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Zanubrutinib for HLH
- Status
- COMPLETED
- Phase
- PHASE3
ZR-CHOP in DLBCL With Specific Gene Abnormality
- Status
- RECRUITING
- Phase
- PHASE2